These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23197779)

  • 1. Concise review: immunomodulatory properties of mesenchymal stem cells in cellular transplantation: update, controversies, and unknowns.
    Atoui R; Chiu RC
    Stem Cells Transl Med; 2012 Mar; 1(3):200-5. PubMed ID: 23197779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myocardial regenerative therapy: immunologic basis for the potential "universal donor cells".
    Atoui R; Shum-Tim D; Chiu RC
    Ann Thorac Surg; 2008 Jul; 86(1):327-34. PubMed ID: 18573459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses after mesenchymal stem cell implantation.
    Atoui R; Chiu RC
    Methods Mol Biol; 2013; 1036():107-20. PubMed ID: 23807791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells as universal donor cells.
    Atoui R; Chiu RC
    Expert Opin Biol Ther; 2012 Oct; 12(10):1293-7. PubMed ID: 22827599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cells can affect solid organ allograft survival.
    Popp FC; Eggenhofer E; Renner P; Geissler EK; Piso P; Schlitt HJ; Dahlke MH
    Transplantation; 2009 May; 87(9 Suppl):S57-62. PubMed ID: 19424009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells and their potential as cardiac therapeutics.
    Pittenger MF; Martin BJ
    Circ Res; 2004 Jul; 95(1):9-20. PubMed ID: 15242981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MSC immune tolerance in cellular cardiomyoplasty.
    Chiu RC
    Semin Thorac Cardiovasc Surg; 2008; 20(2):115-8. PubMed ID: 18707643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
    Le Blanc K; Ringdén O
    Biol Blood Marrow Transplant; 2005 May; 11(5):321-34. PubMed ID: 15846285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges in allogeneic mesenchymal stem cell-mediated cardiac repair.
    Dhingra S; Huang XP; Li RK
    Trends Cardiovasc Med; 2010 Nov; 20(8):263-8. PubMed ID: 22433652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far?
    Griffin MD; Ryan AE; Alagesan S; Lohan P; Treacy O; Ritter T
    Immunol Cell Biol; 2013 Jan; 91(1):40-51. PubMed ID: 23207278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair.
    Huang XP; Sun Z; Miyagi Y; McDonald Kinkaid H; Zhang L; Weisel RD; Li RK
    Circulation; 2010 Dec; 122(23):2419-29. PubMed ID: 21098445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockout of beta-2 microglobulin enhances cardiac repair by modulating exosome imprinting and inhibiting stem cell-induced immune rejection.
    Shao L; Zhang Y; Pan X; Liu B; Liang C; Zhang Y; Wang Y; Yan B; Xie W; Sun Y; Shen Z; Yu XY; Li Y
    Cell Mol Life Sci; 2020 Mar; 77(5):937-952. PubMed ID: 31312880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.
    Nauta AJ; Westerhuis G; Kruisselbrink AB; Lurvink EG; Willemze R; Fibbe WE
    Blood; 2006 Sep; 108(6):2114-20. PubMed ID: 16690970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
    Johnstone BH; Messner F; Brandacher G; Woods EJ
    Front Immunol; 2021; 12():622604. PubMed ID: 33732244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow transplantation combined with mesenchymal stem cells induces immune tolerance without cytotoxic conditioning.
    Wang Y; Liu J; Xu C; Zhang W; Bai L; Li N; Liu Y; Wang Y; Su Y; Hu D
    J Surg Res; 2011 Nov; 171(1):e123-31. PubMed ID: 21920556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal stem cells as an immunomodulatory therapeutic strategy for autoimmune diseases.
    Ben-Ami E; Berrih-Aknin S; Miller A
    Autoimmun Rev; 2011 May; 10(7):410-5. PubMed ID: 21256250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-dose-dependent increases in circulating levels of immune effector cells in rhesus macaques following intracranial injection of allogeneic MSCs.
    Isakova IA; Dufour J; Lanclos C; Bruhn J; Phinney DG
    Exp Hematol; 2010 Oct; 38(10):957-967.e1. PubMed ID: 20600575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory effects of mesenchymal stem cells derived from adipose tissues in a rat orthotopic liver transplantation model.
    Wan CD; Cheng R; Wang HB; Liu T
    Hepatobiliary Pancreat Dis Int; 2008 Feb; 7(1):29-33. PubMed ID: 18234635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune properties of mesenchymal stem cells.
    Sotiropoulou PA; Papamichail M
    Methods Mol Biol; 2007; 407():225-43. PubMed ID: 18453259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.